Please use this identifier to cite or link to this item:
Title: Failure of monoclonal antibodies against CGRP or its receptor does not imply lack of efficacy of other drugs from the same class.
Issue Date: 8-Jul-2021
Citation: Neurologia (Engl Ed).2021;(36)8:638-640
PMID: 34246579
Appears in Collections:Hospitales > H. U. Clínico San Carlos > Artículos
Fundaciones e Institutos de Investigación > IIS H. U. Clínico San Carlos > Artículos

Files in This Item:
The file with the full text of this item is not available due to copyright restrictions or because there is no digital version. Authors can contact the head of the repository of their center to incorporate the corresponding file.

This item is licensed under a Creative Commons License Creative Commons